JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Diploma (LON:DPLM) Stock

Diploma (LON:DPLM) had its target price upped by JPMorgan Chase & Co. from GBX 4,150 ($52.91) to GBX 4,370 ($55.71) in a research report issued on Thursday, Marketbeat reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 3.87% from the company’s current price.

A number of other research analysts have also recently commented on DPLM. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 5,100 ($65.02) target price on shares of Diploma in a research note on Friday, November 22nd. Shore Capital cut Diploma to a “hold” rating in a research note on Tuesday, November 19th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 4,555 ($58.07).

Diploma Price Performance

LON:DPLM opened at GBX 4,546 ($57.96) on Thursday. The company has a current ratio of 2.27, a quick ratio of 0.80 and a debt-to-equity ratio of 45.69. The company has a market capitalization of £6.09 billion, a P/E ratio of 5,286.05, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma has a 12 month low of GBX 3,200 ($40.80) and a 12 month high of GBX 4,653 ($59.32). The business’s 50-day moving average is GBX 4,384.09 and its 200 day moving average is GBX 4,304.25.

Insiders Place Their Bets

In other news, insider Johnny Thomson sold 26,794 shares of the stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($57.83), for a total transaction of £1,215,375.84 ($1,549,433.76). 0.52% of the stock is owned by company insiders.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.